Services
Research
Training
Industry
About us
ChEMBL
ChEMBL
Downloads
UniChem
SureChEMBL
Malaria Data
ChEMBL-NTD
ADME SARfari
Web Services
myChEMBL
EBI RDF Platform
FAQ
Web status page
Funding
Internships
ChEMBL Statistics
Loading Statistics...
ChEMBL Blog
EBI
Databases
Small Molecules
ChEMBL Database
CHEMBL136478
Compound Report Card
Compound Name and Classification
Compound ID
CHEMBL136478
CHEMBL136478
Compound Name
SODIUM NITROPRUSSIDE
ChEMBL Synonyms
NITROPRESS | SODIUM NITROPRUSSIDE | SODIUM NITROFERRICYANIDE | NIPRIDE
Max Phase
4 (Approved)
Trade Names
NIPRIDE | NITROPRESS | SODIUM NITROPRUSSIDE
Molecular Formula
C5FeN6O.2Na
Sources
British National Formulary
DrugMatrix
Orange Book
Scientific Literature
USP Dictionary of USAN and International Drug Names
Molecule Features
Mechanism of Action
Mechanism of Action
ChEMBL Target
References
Soluble guanylate cyclase activator
Soluble guanylate cyclase
DailyMed
PubMed
Indications
MESH Heading
MESH ID
EFO ID
EFO Term
Max phase for indication
References
SCHIZOPHRENIA
D012559
EFO:0000692
SCHIZOPHRENIA
2
ClinicalTrials
MYOCARDIAL INFARCTION
D009203
EFO:0000612
MYOCARDIAL INFARCTION
2
ClinicalTrials
SARCOPENIA
D055948
EFO:1000653
SARCOPENIA
1
ClinicalTrials
AGING
D000375
GO:0007568
AGING
1
ClinicalTrials
HYPERTENSION
D006973
EFO:0000537
HYPERTENSION
3
ClinicalTrials
Clinical Data
ClinicalTrials.gov
SODIUM NITROPRUSSIDE
The Cochrane Collaboration
SODIUM NITROPRUSSIDE
Compound Bioactivity Summary
Compound Assay Summary
Compound Target Summary
Compound Cross References
ChemSpider
ChemSpider Identifier not yet assigned
DailyMed
sodium nitroprusside
Wikipedia
Sodium_nitroprusside